Strategies to Reduce Left Anterior Descending Artery and Left Ventricle Organ Doses in Radiotherapy Planning for Left-Sided Breast Cancer

Background: One of the most significant long-term toxicities of breast cancer radiotherapy is major adverse cardiac events (MACE). In current radiotherapy practice, the mean heart dose is the most commonly used parameter. The aim of our study was to reduce the doses of organs at r...

Full description

Saved in:
Bibliographic Details
Main Authors: Umut Diremsizoglu, Nezihan Topal, Aykut Oguz Konuk, Ibrahim Halil Suyusal, Dogacan Genc, Onur Ari, Hasan Furkan Cevik, Aysegul Ucuncu Kefeli, Maksut Gorkem Aksu, Emine Binnaz Sarper
Format: Article
Language:English
Published: IMR Press 2025-02-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/26/2/10.31083/RCM26366
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850043973620465664
author Umut Diremsizoglu
Nezihan Topal
Aykut Oguz Konuk
Ibrahim Halil Suyusal
Dogacan Genc
Onur Ari
Hasan Furkan Cevik
Aysegul Ucuncu Kefeli
Maksut Gorkem Aksu
Emine Binnaz Sarper
author_facet Umut Diremsizoglu
Nezihan Topal
Aykut Oguz Konuk
Ibrahim Halil Suyusal
Dogacan Genc
Onur Ari
Hasan Furkan Cevik
Aysegul Ucuncu Kefeli
Maksut Gorkem Aksu
Emine Binnaz Sarper
author_sort Umut Diremsizoglu
collection DOAJ
description Background: One of the most significant long-term toxicities of breast cancer radiotherapy is major adverse cardiac events (MACE). In current radiotherapy practice, the mean heart dose is the most commonly used parameter. The aim of our study was to reduce the doses of organs at risk (OAR) in the left anterior descending artery (LAD) and left ventricle (LV) by including the LAD and LV in planning radiotherapy while maintaining adequate dose coverage for patients with left-sided breast cancer. Methods: We retrospectively analyzed left-sided breast cancer cases treated at the Kocaeli University Faculty of Medicine. Only patients with local and locally advanced breast cancer were included in the analysis. A total of 77 patients who were treated between 2020 and 2024 were included. The doses to the LAD and LV were added to the optimization algorithms. Two volumetric modulated arc therapy (VMAT) plans were created for each patient. A total of 154 plans were made, including standard and LAD and LV sparing plans. Results: There was no statistically significant difference in all VMAT plans regarding planning target volume (PTV) D2, D50, and D98 (dose receiving volume of PTV 2%, 50%, and 98%) (p > 0.05). However, a significant decrease was observed in heart V5 (the percentage of the heart receiving at least 5 gray (Gy)) and mean heart dose. A decrease in the mean heart dose was observed in the standard plan compared with the LAD and LV sparing plan (p < 0.001). Similarly, the heart V5 value decreased significantly (p < 0.001). Additionally, significant reductions were measured in all LAD and LV parameters after re-optimization. Conclusions: We achieved significant reductions in all heart, LAD, and LV parameters without making any changes to the planned treatment volume coverage by adding LAD and LV OARs to the optimization algorithms. The potential risk of MACE can be significantly reduced by implementing this strategy.
format Article
id doaj-art-aedeeb061700457b8059e170632c69ff
institution DOAJ
issn 1530-6550
language English
publishDate 2025-02-01
publisher IMR Press
record_format Article
series Reviews in Cardiovascular Medicine
spelling doaj-art-aedeeb061700457b8059e170632c69ff2025-08-20T02:55:06ZengIMR PressReviews in Cardiovascular Medicine1530-65502025-02-012622636610.31083/RCM26366S1530-6550(24)01681-8Strategies to Reduce Left Anterior Descending Artery and Left Ventricle Organ Doses in Radiotherapy Planning for Left-Sided Breast CancerUmut Diremsizoglu0Nezihan Topal1Aykut Oguz Konuk2Ibrahim Halil Suyusal3Dogacan Genc4Onur Ari5Hasan Furkan Cevik6Aysegul Ucuncu Kefeli7Maksut Gorkem Aksu8Emine Binnaz Sarper9Department of Radiation Oncology, School of Medicine, Kocaeli University, 41001 Kocaeli, TurkeyDepartment of Radiation Oncology, School of Medicine, Kocaeli University, 41001 Kocaeli, TurkeyDepartment of Radiation Oncology, School of Medicine, Kocaeli University, 41001 Kocaeli, TurkeyDepartment of Radiation Oncology, School of Medicine, Kocaeli University, 41001 Kocaeli, TurkeyDepartment of Radiation Oncology, School of Medicine, Kocaeli University, 41001 Kocaeli, TurkeyDepartment of Radiation Oncology, School of Medicine, Kocaeli University, 41001 Kocaeli, TurkeyDepartment of Radiation Oncology, School of Medicine, Kocaeli University, 41001 Kocaeli, TurkeyDepartment of Radiation Oncology, School of Medicine, Kocaeli University, 41001 Kocaeli, TurkeyDepartment of Radiation Oncology, School of Medicine, Kocaeli University, 41001 Kocaeli, TurkeyDepartment of Radiation Oncology, School of Medicine, Kocaeli University, 41001 Kocaeli, TurkeyBackground: One of the most significant long-term toxicities of breast cancer radiotherapy is major adverse cardiac events (MACE). In current radiotherapy practice, the mean heart dose is the most commonly used parameter. The aim of our study was to reduce the doses of organs at risk (OAR) in the left anterior descending artery (LAD) and left ventricle (LV) by including the LAD and LV in planning radiotherapy while maintaining adequate dose coverage for patients with left-sided breast cancer. Methods: We retrospectively analyzed left-sided breast cancer cases treated at the Kocaeli University Faculty of Medicine. Only patients with local and locally advanced breast cancer were included in the analysis. A total of 77 patients who were treated between 2020 and 2024 were included. The doses to the LAD and LV were added to the optimization algorithms. Two volumetric modulated arc therapy (VMAT) plans were created for each patient. A total of 154 plans were made, including standard and LAD and LV sparing plans. Results: There was no statistically significant difference in all VMAT plans regarding planning target volume (PTV) D2, D50, and D98 (dose receiving volume of PTV 2%, 50%, and 98%) (p > 0.05). However, a significant decrease was observed in heart V5 (the percentage of the heart receiving at least 5 gray (Gy)) and mean heart dose. A decrease in the mean heart dose was observed in the standard plan compared with the LAD and LV sparing plan (p < 0.001). Similarly, the heart V5 value decreased significantly (p < 0.001). Additionally, significant reductions were measured in all LAD and LV parameters after re-optimization. Conclusions: We achieved significant reductions in all heart, LAD, and LV parameters without making any changes to the planned treatment volume coverage by adding LAD and LV OARs to the optimization algorithms. The potential risk of MACE can be significantly reduced by implementing this strategy.https://www.imrpress.com/journal/RCM/26/2/10.31083/RCM26366left breast cancerleft anterior descending arteryleft ventriclemajor adverse cardiac events
spellingShingle Umut Diremsizoglu
Nezihan Topal
Aykut Oguz Konuk
Ibrahim Halil Suyusal
Dogacan Genc
Onur Ari
Hasan Furkan Cevik
Aysegul Ucuncu Kefeli
Maksut Gorkem Aksu
Emine Binnaz Sarper
Strategies to Reduce Left Anterior Descending Artery and Left Ventricle Organ Doses in Radiotherapy Planning for Left-Sided Breast Cancer
Reviews in Cardiovascular Medicine
left breast cancer
left anterior descending artery
left ventricle
major adverse cardiac events
title Strategies to Reduce Left Anterior Descending Artery and Left Ventricle Organ Doses in Radiotherapy Planning for Left-Sided Breast Cancer
title_full Strategies to Reduce Left Anterior Descending Artery and Left Ventricle Organ Doses in Radiotherapy Planning for Left-Sided Breast Cancer
title_fullStr Strategies to Reduce Left Anterior Descending Artery and Left Ventricle Organ Doses in Radiotherapy Planning for Left-Sided Breast Cancer
title_full_unstemmed Strategies to Reduce Left Anterior Descending Artery and Left Ventricle Organ Doses in Radiotherapy Planning for Left-Sided Breast Cancer
title_short Strategies to Reduce Left Anterior Descending Artery and Left Ventricle Organ Doses in Radiotherapy Planning for Left-Sided Breast Cancer
title_sort strategies to reduce left anterior descending artery and left ventricle organ doses in radiotherapy planning for left sided breast cancer
topic left breast cancer
left anterior descending artery
left ventricle
major adverse cardiac events
url https://www.imrpress.com/journal/RCM/26/2/10.31083/RCM26366
work_keys_str_mv AT umutdiremsizoglu strategiestoreduceleftanteriordescendingarteryandleftventricleorgandosesinradiotherapyplanningforleftsidedbreastcancer
AT nezihantopal strategiestoreduceleftanteriordescendingarteryandleftventricleorgandosesinradiotherapyplanningforleftsidedbreastcancer
AT aykutoguzkonuk strategiestoreduceleftanteriordescendingarteryandleftventricleorgandosesinradiotherapyplanningforleftsidedbreastcancer
AT ibrahimhalilsuyusal strategiestoreduceleftanteriordescendingarteryandleftventricleorgandosesinradiotherapyplanningforleftsidedbreastcancer
AT dogacangenc strategiestoreduceleftanteriordescendingarteryandleftventricleorgandosesinradiotherapyplanningforleftsidedbreastcancer
AT onurari strategiestoreduceleftanteriordescendingarteryandleftventricleorgandosesinradiotherapyplanningforleftsidedbreastcancer
AT hasanfurkancevik strategiestoreduceleftanteriordescendingarteryandleftventricleorgandosesinradiotherapyplanningforleftsidedbreastcancer
AT aysegulucuncukefeli strategiestoreduceleftanteriordescendingarteryandleftventricleorgandosesinradiotherapyplanningforleftsidedbreastcancer
AT maksutgorkemaksu strategiestoreduceleftanteriordescendingarteryandleftventricleorgandosesinradiotherapyplanningforleftsidedbreastcancer
AT eminebinnazsarper strategiestoreduceleftanteriordescendingarteryandleftventricleorgandosesinradiotherapyplanningforleftsidedbreastcancer